Summary.-The nitro -aromatic radiosensitizing drugs are selectively toxic to hypoxic mammalian cells, and this toxicity can be greatly increased by the addition of ascorbate. The ascorbate itself is not toxic to either hypoxic or aerobic cells (as long as catalase is present to prevent the formation of significant concentrations of hydrogen peroxide) and the mixture of ascorbate plus radiosensitizer is not more toxic to aerobic cells.
Summary.-The nitro -aromatic radiosensitizing drugs are selectively toxic to hypoxic mammalian cells, and this toxicity can be greatly increased by the addition of ascorbate. The ascorbate itself is not toxic to either hypoxic or aerobic cells (as long as catalase is present to prevent the formation of significant concentrations of hydrogen peroxide) and the mixture of ascorbate plus radiosensitizer is not more toxic to aerobic cells.
Sulphydryl reducing agents and dithionite have an effect opposite to ascorbate and decrease the toxicity of nitro-aromatic drugs under hypoxic conditions. Sulphydryl reducing agents are also reported to nullify the radiosensitizing properties of nitroaromatic drugs, in contrast to ascorbate which has no effect on the radiosensitizing properties.
The toxicity of nitro-aromatic drugs decreases rapidly with increasing 02 con- centration. This decrease is much less rapid when ascorbate is present. The role of ascorbate in this case may be primarily as an 02 scavenger, although it is also possible that the toxic species produced by radiosensitizer-ascorbate mixtures is less easily removed or detoxified by 02
A MIAJOR GOAL of radiobiology in the past few years has been to eliminate tumour cells which are resistant to conventional treatment. The hypoxic cell is very resistant to radiation and perhaps chemicals as well (since it may be isolated from the blood supply) and a major effort has been undertaken to find chemicals or techniques which might sensitize these cells (hyperbaric 02, hyperthermia, hypoxic-cell radiosensitizing agents). The last method is concerned almost exclusively with nitro-aromatic compounds (Adams & Cooke, 1969; Chapman et al., 1974) , although other oxidizing agents have also been considered (Koch and Biaglow, 1 978a; for review see Mitchell & Marrian, 1965) .
In addition to their radiosensitizing properties, the selective killing of hypoxic cells by these oxidizing agents is now clearly established Mohindra & Rauth, 1976; Sridhar et al., 1976; Koch & Biaglow, 1978a) . This cytotoxicity has been enhanced by ascorbate (ASC) (misonidazole (MIS) and ASC; Josephy et al., 1978) , hyperthermia (MIS and heat; Sridhar & Sutherland, 1977; Stratford & Adams, 1977; Hall et al., 1977) and serum (Stratford & Gray, 1978) , but diminished by 02 (Mohindra & Rauth, 1976; Koch & Biaglow, 1978a; and sulphydryl agents (Hall et al., 1977) . The opposite effects of reducing agents (ASC enhances, sulphydryls such as glutathione, cysteine, cysteamine and (Mohindra & Rauth, 1976;  Koch & Biaglow, 1978a; has not been explained, although it is thought that 02 may accept electrons from potentially damaging species with the resultant oxygen radicals being detoxified by catalase and superoxide dismutase (Biaglow et al., 1976; Biaglow et al., 1978) .
Because of this effect of small amounts of 02, it is remarkable that killing of hypoxic cells in vivo (Brown, 1977) and in multicell spheroids (Sridhar et al., 1976) by MIS has been found. In both of these cases one might expect far more hypoxic than anoxic cells and hence little killing. In mouse tumours, one would imagine even less chance of any cytotoxic effects, because of the short half-life of MIS in the serum (about 1 h; Rauth et al., 1978) particularly since there always appears to be an initial period of resistance to the cytotoxicity of these compounds (Sridhar et al., 1976; Hall et al., 1977; Stratford & Gray, 1978;  and in this paper).
In this report, we present additional data on the synergistic toxicities of ASC in combination with nitro-aromatic drugs, in the presence or absence of small amounts of 02. The bulk of the data in this report concerns the drug MIS which is currently undergoing clinical trials as a hypoxic-cell radio-sensitizing agent. The day before an experiment, 2 x105 exponentially growing cells were inoculated on to glass Petri dishes (50 mm, Pyrex, Corning). The next day, the medium was aspirated from the dishes and 2-5 ml of freshly prepared drug-containing medium was added to each dish at room temperature. The dishes were placed in air-tight aluminium chambers ( Fig. 1 ) and the gas inside was replaced by either 95% N2+5% CO2 (02 <5 pts/106) or 94.8% N2+5% C02+0-2% 02, in a series of gas changes taking 4-5 h (Koch & Painter, 1975) . During this deoxygenating procedure the chambers were kept at 0°C. All drugs tested were completely nontoxic at 0°C, and the deoxygenating procedure did not reduce the plating efficiency (typically 80%). For control points, which were to be incubated with drug-containing medium in air, 95% air+5% CO2 was added at the 4 h point of the degassing procedure (Koch et al., 1977) . The auto-oxidation of ascorbate (or other reducing agents) leads to the production of hydrogen peroxide, which is very toxic. To prevent this toxicity, catalase was added (Fungal, A. niger-Calbiochem, 9440 u/mg) at a concentration of 50 u/ml of medium (Peterkofsky & Prather, 1977; Koch & Biaglow, 1978a) . The catalase had no other detectable effects and was used in all plates of all experiments to maintain uniformity.
MATERIALS AND METHODS

Most
The chambers were then placed in a water bath at 37°C for the desired time, after which they were opened. The dishes were rinsed with trypsin (GIBCO, 0-05%), and the cells removed from the dish by incubation in 1 ml of trypsin for 10 min. The cells were counted and plated in appropriate numbers on dishes containing 5 ml of BME. These dishes were incubated for one week and survival was assayed by counting colonies of more than 50 cells. Data were plotted as a fraction of the control plating efficiency (i.e. dishes which were deoxygenated at 0°C and plated immediately) which was typically 80%.
In some experiments the cells were irradiated by placing the chambers on a rotating platform in the field of a 60Co y-ray unit, at a dose rate of --280 rad/min (Koch et al., 1977) . The dose rate was determined by TLD measurements on plastic dishes, with glass backscatter assayed by determining the dose correction factor to achieve the same survival on glass as in plastic (this correction was 1-05).
Chemical measurements of the rate of oxidation of ascorbate were made by monitoring the fall of 02 concentration with time, using a polarographic 02 electrode in a sealed vessel which was stirred constantly. The vessel was airtight except for a tiny capillary opening through which one could admit various reagents by means of a micro syringe (Biaglow et al., 1976; Koch & Biaglow, 1978b) .
RESULTS
The basic feature of the cytotoxicity of these drugs is an initial 1-2 h period of resistance followed by an exponential Non-drug controls (-, A).
C (H) decrease in survival with time (Fig. 2) . For metronidazole (MET), MIS and the nitrofuran 5-nitro-2-furaldehyde 5-(3-diethamiono propyl) semioxamazone HC1 (NF-167) ASC appears to potentiate the toxicity by increasing the slope of the exponential part of the curve, while apparently not affecting the initial period of drug resistance. This is seen more clearly in an experiment illustrating the toxicity of 5 mm MIS ± 5 mm ASC, where there is practically no killing for 0, 2 and 1 h (Fig. 3) . The potentiation by MIS of the autooxidation of ASC was studied as a function of concentration of both drugs (Fig. 4a) . At all concentrations studied, MIS enhanced the rate of 02 consumption. This potentiation of auto-oxidation also occurs in complete medium, and the amount of potentiation is verly similar, although the overall reaction rates are somewhat different (Fig. 4b) .
If (Table) .
DISCUSSION
The results presented here clearly demonstrate the possible benefits of combined ascorbate-sensitizer with respect to hypoxic-cell killing in vitro (Figs.  2, 3, 6, 7) . The effects of high doses of ASC in vivo, however, are more difficult to predict. For example, ASC could on the one hand increase the cytotoxicity of radio-sensitizing drugs, but on the other hand increase the fraction of hypoxic cells, through auto-oxidation processes (Fig. 4) . This, in fact, may be the cause of the increased cytotoxicity seen with ASC-MIS at a gas-phase 02 partial-pressure of 2000 pts/106 (Fig. 6) ; in other words, the auto-oxidation of ascorbate decreases the concentration of 02 in the medium below the gas-phase value. However, in vivo, the rate of cellular 02 consumption would be about 5 4 x 10-2 mol/h [assuming a cell concentration of 5 x108/g and an 02 consumption rate of 5 x 10-17 mol/ cell/sec (Koch & Biaglow, 1978b) ]. In contrast, the auto-oxidation rate of 2 mm ASC+2 mm MIS in BME is about 500 x less than this (Fig. 4b) . Thus, the autooxidation of vitamin C would not be expected to change the overall 02 concentration significantly, except perhaps in local areas where the 02 concentration was already very low.
The contrasting effects of ascorbate and SH-containing compounds warrant considerable further investigation. In particular, combinations of sensitizer, ASC, and RSH should be tested in the cytotoxicity assay. This is essential, to show which effect predominates (enhancement of toxicity by ASC, reduction of toxicity by RSH) and whether there is a chemical competition between the effects. A significant concentration of RSH or RSSR certainly exists in vivo. One published report has shown that cysteamine protects against both the radiosensitizing and cytotoxic effects at about the same con-22 centration (Hall et al., 1977) . Thus the fact that significant radiosensitization has been shown for hypoxic cells in vivo already suggests that free SH may not be high enough to be a significant problem in the use of agents like MIS. In addition it is necessary to identify the precise concentrations of ASC or RSH necessary to achieve full potentiation or decrease in cytotoxicity. Preliminary evidence would indicate that 1 mm ASC is just as effective as 5 mm (Fig. 6) .
This points to important differences between our results and those of Josephy et al. (1978) . Those investigators found a greater potentiation by ascorbate of the cytotoxicity of MIS than we did, and in addition, found a significant dependence of the cytotoxicity on vitamin C concentration. They also found potentiation of the cytotoxicity of MIS by glutathione. We believe that these discrepancies can be explained by incomplete 02 removal from their test system. This would explain the relatively smaller amount of toxicity seen for 5 and 15 mm MIS alone (compared with other reports -Hall et al, 1977; Stratford & Adams, 1977; Mohindra & Rauth, 1976 ; this paper) because of the protective effect of 02 (Fig. 6) . Thus the addition of ASC would not only increase the cytotoxicity, but decrease the 02 concentration ( Fig. 6 and see previous discussion). Finally, the small amount of potentiation reported by Josephy et al. for glutathione could also be caused by auto-oxidation of glutathione, leading to reduced 02 levels. The protection by RSH of the cytotoxicity of MIS observed in our results agrees completely with a previous report by Hall et al. (1977) , who found that cysteamine not only nullified the cytotoxicity of MIS, but also cancelled its radiosensitizing properties. Our results show that ASC potentiated the cytotoxicity and did not affect the radiosensitizing properties of MIS (Fig. 5) .
A major problem in the comparison of the cytotoxic effects of misonidazole in different laboratories involves traces of 02, and components of serum which are as yet unidentified. Thus, Mohindra & Rauth (1976) and have found that relatively small concentrations Of 02 can greatly reduce the cytotoxic effects of radiosensitizers (Fig. 6) Thus, Stratford & Gray (1978) found potentiation of cytotoxicity by serum whereas we have found reduction of cytotoxicity by serum. In retrospect these differences might be expected, since the action of reducing agents like ASC and RSH are opposite. However, it is of interest that the survival curves (2 mM MIS, extreme hypoxia) for the V79 cells used by Stratford & Gray (1978) and for the V79 cells used in our present experiments are very similar when no serum is present (compare This important internal agreement suggests that the serum effects are real and that the chemicals responsible should be identified. Finally, at the chemical level, we still do not understand the role of ASC in the killing of hypoxic cells by agents like MIS and indeed the toxic species itself has not been identified. If the toxic species is the same for both MIS and (MIS+ ASC), ASC is probably acting by increasing the reduction (presumably metabolic) of MIS to a more harmful species. Alternatively, the increased toxicity may be caused by an oxidation product of vitamin C (e.g. semi-quinone), whose mode of action may be similar to that of dehydroascorbic acid (Koch & Biaglow, 1978a) . Our current experiments are aimed at trying to elucidate the killing mechanisms for these drugs.
